TG Therapeutics, Inc. has announced its schedule for presenting data on BRIUMVI® (ublituximab-xiiy) at the upcoming American Academy of Neurology 2025 annual meeting in San Diego, California, from ...

NeuroPace, Inc., a medical device company focused on improving the lives of individuals with epilepsy, has announced that an abstract from its Post-approval Study of the RNS System will be presented ...

This poster describes the data around a novel breakthrough therapeutic (VCA-894A) customized to a specific genetic mutation of a patient with Charcot-Marie-Tooth disease type 2S (CMT2S). The effects ...

— Encora breakthrough pivotal data demonstrating superiority over sham recognized as top rated Movement Disorders abstract — Encora Therapeutics today announced that its abstract, Safety and Efficacy ...

VALBY, Denmark, April 4, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this episode of Meeting Mic, we bring you pearls and ...

MINNEAPOLIS — Press registration is now open for journalists who would like to attend the 78th Annual Meeting of the American Academy of Neurology (AAN). The 2026 AAN Annual Meeting will be held from ...

Upsher-Smith’s rare disease portfolio continues to grow with the addition of high-quality medications that match or exceed the level of service provided by innovator brands. The Company offers three ...

PARAMUS, N.J., April 4, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in developing treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., ...

SAN DIEGO--(BUSINESS WIRE)--Encora Therapeutics today announced that its abstract, Safety and Efficacy of a Wrist-worn Vibratory Stimulation Wearable for Upper Limb Tremor Reduction in Essential ...